SCHEMBL30976441

SCHEMBL30976441

COc1ccccc1N1CCN(C(=O)c2nn(CC(C)C)c(=O)c3ccccc23)CC1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.71
▸ DRD2 P14416 1/20 0.59
▸ HTR2A P28223 1/20 0.59
▸ MAPT P10636 3/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ TP53 P04637 3/20 0.53
▸ LMNA P02545 1/20 0.53
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ USP2 O75604 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ KDM4E B2RXH2 2/20 0.51
▸ GAA P10253 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ NPC1 O15118 1/20 0.49
▸ POLB P06746 2/20 0.48
▸ GLA P06280 1/20 0.48
▸ HPGDS O60760 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30976274 0.87 ALDH1A1 (0.53) NPSR1MAPTSMN1; SMN2LMNAMEN1
SCHEMBL30976350 0.87 ALDH1A1 (0.53) NPSR1MAPTLMNAMEN1KMT2A
SCHEMBL30976422 0.85 HTT (0.59) NPSR1MAPTSMN1; SMN2TP53LMNA
SCHEMBL30976246 0.85 NPSR1 (0.76) NPSR1DRD2HTR2AMAPTSMN1; SMN2
SCHEMBL30976393 0.84 MAPT (0.58) NPSR1MAPTSMN1; SMN2TP53LMNA
SCHEMBL30976461 0.83 NPSR1 (1.00) NPSR1DRD2HTR2AMAPTSMN1; SMN2
SCHEMBL30976305 0.83 ALDH1A1 (0.58) NPSR1MAPTSMN1; SMN2TP53MEN1
SCHEMBL30976331 0.82 ALDH1A1 (0.62) NPSR1MAPTLMNAMEN1KMT2A
SCHEMBL30976475 0.80 TP53 (0.57) NPSR1MAPTSMN1; SMN2TP53LMNA
SCHEMBL30976285 0.80 ALDH1A1 (0.77) NPSR1MAPTSMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 — — EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 — — WO disclosed
Send feedback